IL91138A - Immunosuppressive preparations containing Imaxon - Google Patents

Immunosuppressive preparations containing Imaxon

Info

Publication number
IL91138A
IL91138A IL9113889A IL9113889A IL91138A IL 91138 A IL91138 A IL 91138A IL 9113889 A IL9113889 A IL 9113889A IL 9113889 A IL9113889 A IL 9113889A IL 91138 A IL91138 A IL 91138A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
imexon
compositions according
treatment
proliferation
Prior art date
Application number
IL9113889A
Other languages
English (en)
Hebrew (he)
Other versions
IL91138A0 (en
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL91138A0 publication Critical patent/IL91138A0/xx
Publication of IL91138A publication Critical patent/IL91138A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
IL9113889A 1988-07-28 1989-07-27 Immunosuppressive preparations containing Imaxon IL91138A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3825667A DE3825667A1 (de) 1988-07-28 1988-07-28 Verwendung von imexon als immunsuppressivum

Publications (2)

Publication Number Publication Date
IL91138A0 IL91138A0 (en) 1990-03-19
IL91138A true IL91138A (en) 1994-10-21

Family

ID=6359767

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9113889A IL91138A (en) 1988-07-28 1989-07-27 Immunosuppressive preparations containing Imaxon

Country Status (14)

Country Link
EP (1) EP0352652B1 (fr)
JP (1) JP2848634B2 (fr)
KR (1) KR0135757B1 (fr)
AT (1) ATE117551T1 (fr)
AU (1) AU619027B2 (fr)
CA (1) CA1333771C (fr)
DE (2) DE3825667A1 (fr)
DK (1) DK175199B1 (fr)
HU (1) HU206827B (fr)
IE (1) IE66680B1 (fr)
IL (1) IL91138A (fr)
PH (1) PH26684A (fr)
PT (1) PT91293B (fr)
ZA (1) ZA895710B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005055952A2 (fr) * 2003-12-08 2005-06-23 The Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions anticancereuses synergiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2528460A1 (de) * 1975-06-26 1977-01-13 Boehringer Mannheim Gmbh Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE2530398A1 (de) * 1975-07-08 1977-01-27 Boehringer Mannheim Gmbh Organische verbindung
DE2736296A1 (de) * 1977-08-12 1979-02-22 Boehringer Mannheim Gmbh Verwendung von 2-cyan-aziridin und seinen derivaten zur immunstimulierung

Also Published As

Publication number Publication date
PT91293A (pt) 1990-02-08
IE66680B1 (en) 1996-01-24
ZA895710B (en) 1990-04-25
HUT52378A (en) 1990-07-28
PT91293B (pt) 1995-03-01
DE3825667A1 (de) 1990-03-15
DK175199B1 (da) 2004-07-05
HU206827B (en) 1993-01-28
IE892448L (en) 1990-01-28
JP2848634B2 (ja) 1999-01-20
DE3825667C2 (fr) 1991-06-27
KR0135757B1 (ko) 1998-04-23
CA1333771C (fr) 1995-01-03
PH26684A (en) 1992-09-15
IL91138A0 (en) 1990-03-19
ATE117551T1 (de) 1995-02-15
AU619027B2 (en) 1992-01-16
EP0352652A3 (fr) 1991-09-04
AU3887789A (en) 1990-02-01
KR900001369A (ko) 1990-02-27
DE58908926D1 (de) 1995-03-09
EP0352652A2 (fr) 1990-01-31
EP0352652B1 (fr) 1995-01-25
DK363389A (da) 1990-01-29
DK363389D0 (da) 1989-07-21
JPH0288521A (ja) 1990-03-28

Similar Documents

Publication Publication Date Title
JP4382164B2 (ja) 求核性置換エクテイナシジン類およびｎ−オキシドエクテイナシジン類
JPH06234635A (ja) インターロイキン１ベータを阻害するためのレフルノミドの使用
US5547970A (en) Use of leflunomide for inhibiting tumor necrosis factor alpha
US20060116337A1 (en) Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors
US5369119A (en) Use of imexon as an immune suppressive and pharmaceutical compositions containing imexon
US5547971A (en) Use of leflunomide for inhibiting interleukin 8
US6034100A (en) Method for inhibiting cytokine secretion
AU619027B2 (en) Method for suppressing immune responses by administering imexon
AU702727B2 (en) Arteriosclerosis depressant
US7482362B2 (en) Substituted-4-quinolones
CN116615200A (zh) 哒嗪衍生物的晶型
KR0185226B1 (ko) 이식 조직의 거부반응 억제제 및 il-1 생산 억제제
US4883808A (en) Condensation products of cyclic diketones and ascorbic acid as immunomodulatory agents
JPS63264527A (ja) 抗エイズウイルス剤
JP4781624B2 (ja) Ｒａｎｔｅｓ誘導剤
JPH03501387A (ja) ケトブチロラクトン及びフリルブチロラクトンを用いて哺乳類の炎症を治療する方法
DE3844839C2 (de) Verwendung von Imexon als Immunsuppressivum
DE3844655A1 (de) Verwendung von imexon als immunsuppressivum
JPS60184012A (ja) 免疫調整剤
JPH07165577A (ja) ３ーオキシゲルミルプロピオン酸化合物並びに該化合物を主成分とする肝障害の予防及び治療剤
JPH0637500B2 (ja) Ｋｂｂｌのガン治療用途
JPH0640908A (ja) 免疫抑制剤
JPH0959260A (ja) チアミンジスルフィド類及びこれを有効成分とする医薬

Legal Events

Date Code Title Description
KB Patent renewed
HP Change in proprietorship
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees